Surgical Management of Retroperitoneal Sarcoma
Current Oncology · 2023
DOI: 10.3390/curroncol30050349 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Oncology, 2023. Verfasst von Dana A Dominguez und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Surgical Oncology, Department of Surgery, City of Hope National Medical Center, 1500 East Duarte Road, Duarte, CA 91010, USA. Hauptthemen laut MEDLINE: Sarcoma, Retroperitoneal Neoplasms, Soft Tissue Neoplasms. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Leiomyosarcoma Support and Direct Research Foundation.
Abstract (Originalsprache)
Surgery is the cornerstone of treatment for retroperitoneal sarcoma (RPS). Surgery should be performed by a surgical oncologist with sub-specialization in this disease and in the context of a multidisciplinary team of sarcoma specialists. For primary RPS, the goal of surgery is to achieve the complete en bloc resection of the tumor along with involved organs and structures to maximize the clearance of the disease. The extent of resection also needs to consider the risk of complications. Unfortunately, the overarching challenge in primary RPS treatment is that even with optimal surgery, tumor recurrence occurs frequently. The pattern of recurrence after surgery (e.g., local versus distant) is strongly associated with the specific histologic type of RPS. Radiation and systemic therapy may improve outcomes in RPS and there is emerging data studying the benefit of non-surgical treatments in primary disease. Topics in need of further investigation include criteria for unresectability and management of locally recurrent disease. Moving forward, global collaboration among RPS specialists will be key for continuing to advance our understanding of this disease and find more effective treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Surgical Oncology, Department of Surgery, City of Hope National Medical Center, 1500 East Duarte Road, Duarte, CA 91010, USA.
- Department of Radiation Oncology, City of Hope National Medical Center, 1500 East Duarte Road, Duarte, CA 91010, USA.
- Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, 1500 East Duarte Road, Duarte, CA 91010, USA.
- Department of Pathology, City of Hope National Medical Center, 1500 East Duarte Road, Duarte, CA 91010, USA.
- Department of Diagnostic Radiology, City of Hope National Medical Center, 1500 East Duarte Road, Duarte, CA 91010, USA.
- Division of Thoracic Surgery (Vascular Surgery Section), City of Hope National Medical Center, 1500 East Duarte Road, Duarte, CA 91010, USA.
ORCID-Profile: Dana A Dominguez, Mark Agulnik
Förderung
- Leiomyosarcoma Support and Direct Research Foundation
Zitieren
APA
Dominguez, D. A., Sampath, S., Agulnik, M., Liang, Y., Nguyen, B., Trisal, V., Melstrom, L. G., Lewis, A. G., Paz, I. B., Roberts, R. F., & Tseng, W. W. (2023). Surgical Management of Retroperitoneal Sarcoma. Current Oncology. https://doi.org/10.3390/curroncol30050349
Vancouver
Dominguez DA, Sampath S, Agulnik M, Liang Y, Nguyen B, Trisal V, et al. Surgical Management of Retroperitoneal Sarcoma. Current Oncology. 2023. doi:10.3390/curroncol30050349
BibTeX
@article{Dominguez2023,
author = {Dominguez, Dana A and Sampath, Sagus and Agulnik, Mark and Liang, Yu and Nguyen, Bao and Trisal, Vijay and Melstrom, Laleh G and Lewis, Aaron G and Paz, Isaac Benjamin and Roberts, Randall F and Tseng, William W},
title = {Surgical Management of Retroperitoneal Sarcoma},
journal = {Current Oncology},
year = {2023},
doi = {10.3390/curroncol30050349}
}
EUVIMED